Sg3 Management, LLC Iovance Biotherapeutics, Inc. Put Options Transaction History

Sg3 Management, LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2022 Feb 14, 2023	BUY	$5.62 - $10.0 $505,800 - $900,000	90,000 New	90,000 $575,000
Q3 2021 Nov 15, 2021	SELL	$20.35 - $26.63 $1.08 Million - $1.41 Million	-53,000 Reduced 41.41%	75,000 $1.85 Million
Q4 2020 Feb 16, 2021	SELL	$28.04 - $50.26 $1.4 Million - $2.51 Million	-50,000 Reduced 28.09%	128,000 $5.94 Million
Q3 2020 Nov 13, 2020	BUY	$27.75 - $36.3 $4.94 Million - $6.46 Million	178,000 New	178,000 $5.86 Million

320

238M

1.27M

1.68M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.74B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.